New study aims to unravel cancer blood clot mysteries

NCT ID NCT06393764

Recruiting now Knowledge-focused Sponsor: University Hospital, Brest Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is collecting blood and urine samples from 150 cancer patients who have had blood clots. The goal is to learn more about why clots happen in cancer and how to prevent them. Participants will be followed over time to track clot recurrence and bleeding risks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better predict and manage blood clots in cancer patients, potentially reducing complications.
What could go wrong: This is an observational study, not a treatment trial. It may not lead to direct patient benefits, and results may take years to apply in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer Embolism and Thrombosis neoplasm thrombotic disease venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER THROMBOSES, VENOUS THROMBOSIS EMBOLISM

Contacts and locations

Locations

Brest University Hospital
RECRUITING

Brest, 29200, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.